Sutro Biopharma, Inc.
STRO- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001382101
No open-market purchases or sales by Sutro Biopharma, Inc. insiders were filed in the last 90 days; 100 institutions reported holding it in 13F filings for Q2 2026, worth $545.7M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Sutro Biopharma, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 138 | 124 | −14 |
| Shares | 44.4M | 41.2M | −3.14M (−7.1%) |
| Value | $1.01B | $766.7M | −$242.8M (−24.1%) |
New holders (12)
Institutions that held Sutro Biopharma, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Swiss National Bank | 70,800 | $1.32M | 0.00% |
| Principal Financial Group Inc | 67,809 | $1.26M | 0.00% |
| Balyasny Asset Management LLC | 61,432 | $1.14M | 0.01% |
| Los Angeles Capital Management LLC | 43,754 | $813.0K | 0.00% |
| Allianz Asset Management GmbH | 40,515 | $753.0K | 0.00% |
| Squarepoint Ops LLC | 34,877 | $648.0K | 0.00% |
| Hudson Bay Capital Management LP | 25,000 | $465.0K | 0.01% |
| Credit Suisse AG | 19,287 | $358.0K | 0.00% |
| Dynamic Technology Lab Private Ltd | 15,548 | $289.0K | 0.03% |
| Engineers Gate Manager LP | 14,500 | $270.0K | 0.02% |
| Blueshift Asset Management, LLC | 13,189 | $245.0K | 0.01% |
| Quantbot Technologies LP | 900 | $16.0K | 0.00% |
Sold out (26)
Institutions that held Sutro Biopharma, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.